Insufficient scRNA-seq data for expression of PHKG1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 508.69 | 2594 / 2642 | 100% | 52.30 | 703 / 705 |
prostate | 81% | 148.39 | 199 / 245 | 83% | 1.91 | 418 / 502 |
breast | 93% | 213.30 | 426 / 459 | 65% | 3.63 | 723 / 1118 |
adrenal gland | 98% | 283.71 | 253 / 258 | 45% | 1.67 | 104 / 230 |
ovary | 77% | 111.51 | 139 / 180 | 61% | 1.12 | 263 / 430 |
intestine | 83% | 376.52 | 805 / 966 | 51% | 1.09 | 271 / 527 |
esophagus | 36% | 72.83 | 525 / 1445 | 95% | 3.02 | 174 / 183 |
lung | 68% | 98.96 | 394 / 578 | 52% | 1.20 | 603 / 1155 |
uterus | 73% | 113.79 | 124 / 170 | 44% | 1.04 | 201 / 459 |
thymus | 80% | 134.67 | 520 / 653 | 34% | 0.49 | 206 / 605 |
skin | 73% | 168.16 | 1314 / 1809 | 38% | 0.83 | 180 / 472 |
bladder | 57% | 260.19 | 12 / 21 | 47% | 1.03 | 239 / 504 |
muscle | 100% | 7033.58 | 803 / 803 | 0% | 0 | 0 / 0 |
stomach | 28% | 61.21 | 102 / 359 | 68% | 1.58 | 195 / 286 |
heart | 94% | 846.41 | 806 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 90% | 268.36 | 1208 / 1335 | 0% | 0 | 0 / 0 |
adipose | 78% | 204.48 | 945 / 1204 | 0% | 0 | 0 / 0 |
spleen | 66% | 80.48 | 160 / 241 | 0% | 0 | 0 / 0 |
pancreas | 6% | 7.06 | 21 / 328 | 54% | 1.11 | 97 / 178 |
kidney | 20% | 20.62 | 18 / 89 | 39% | 0.75 | 347 / 901 |
eye | 0% | 0 | 0 / 0 | 55% | 1.23 | 44 / 80 |
lymph node | 0% | 0 | 0 / 0 | 38% | 0.53 | 11 / 29 |
tonsil | 0% | 0 | 0 / 0 | 33% | 0.76 | 15 / 45 |
peripheral blood | 25% | 31.37 | 235 / 929 | 0% | 0 | 0 / 0 |
liver | 7% | 7.66 | 16 / 226 | 13% | 0.24 | 52 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0005978 | Biological process | glycogen biosynthetic process |
GO_0005964 | Cellular component | phosphorylase kinase complex |
GO_0005829 | Cellular component | cytosol |
GO_0019899 | Molecular function | enzyme binding |
GO_0005516 | Molecular function | calmodulin binding |
GO_0050321 | Molecular function | tau-protein kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004689 | Molecular function | phosphorylase kinase activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | PHKG1 |
Protein name | Phosphorylase kinase catalytic subunit gamma 1 Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHK-gamma-M) (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-1) (Serine/threonine-protein kinase PHKG1) (EC 2.7.11.1, EC 2.7.11.26) phosphorylase kinase (EC 2.7.11.19) |
Synonyms | PHKG |
Description | FUNCTION: Catalytic subunit of the phosphorylase b kinase (PHK), which mediates the neural and hormonal regulation of glycogen breakdown (glycogenolysis) by phosphorylating and thereby activating glycogen phosphorylase. In vitro, phosphorylates PYGM, TNNI3, MAPT/TAU, GAP43 and NRGN/RC3 (By similarity). . |
Accessions | ENST00000395428.3 Q6NSZ4 ENST00000432123.5 C9JME8 ENST00000297373.7 [Q16816-1] Q16816 F8WD25 ENST00000446428.5 ENST00000452681.6 [Q16816-2] C9J2Q6 |